A double-blind randomised placebo-controlled trial of topical nasal steroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care

Trial Profile

A double-blind randomised placebo-controlled trial of topical nasal steroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Mometasone (Primary)
  • Indications Otitis media
  • Focus Therapeutic Use
  • Acronyms GNOME
  • Most Recent Events

    • 22 Mar 2010 Results published in Value in Health.
    • 22 Apr 2009 Planned number of patients changed from 388 to 400 and additional lead trial centre identified as reported by United Kingdom Clinical Research Network record.
    • 22 Apr 2009 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top